DK0944611T3 - Dimesylatsalte af neuropeptid Y-ligander - Google Patents

Dimesylatsalte af neuropeptid Y-ligander

Info

Publication number: DK0944611T3
Authority: DK; Denmark
Prior art keywords: neuropeptide; ligands; dimesylate; salts; dimesylate salts
Prior art date: 1996-11-26

Application number

DK97910602T

Other languages

English (en)

Inventor

Douglas J M Allen

Lyle R Brostrom

Alireza S Kord

Laurie A Whipple

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-26

Filing date

1997-11-19

Publication date

2004-04-13

1997-11-19 Application filed by Pfizer filed Critical Pfizer

2004-04-13 Application granted granted Critical

2004-04-13 Publication of DK0944611T3 publication Critical patent/DK0944611T3/da

Links

101710151321 Melanostatin Proteins 0.000 title 1
102400000064 Neuropeptide Y Human genes 0.000 title 1
239000003446 ligand Substances 0.000 title 1
URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Child & Adolescent Psychology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK97910602T 1996-11-26 1997-11-19 Dimesylatsalte af neuropeptid Y-ligander DK0944611T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3181596P	1996-11-26	1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en)	1996-11-26	1997-11-19	Dimesylate salts of neuropeptide y ligands

Publications (1)

Publication Number	Publication Date
DK0944611T3 true DK0944611T3 (da)	2004-04-13

Family

ID=21861551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97910602T DK0944611T3 (da)	1996-11-26	1997-11-19	Dimesylatsalte af neuropeptid Y-ligander

Country Status (23)

Country	Link
US (1)	US5914329A (da)
EP (1)	EP0944611B1 (da)
JP (1)	JP3120861B2 (da)
AP (1)	AP9701148A0 (da)
AR (1)	AR010304A1 (da)
AT (1)	ATE257472T1 (da)
AU (1)	AU4792497A (da)
BR (1)	BR9713538A (da)
CA (1)	CA2272927C (da)
DE (1)	DE69727155T2 (da)
DK (1)	DK0944611T3 (da)
ES (1)	ES2213207T3 (da)
GT (1)	GT199700123A (da)
HN (1)	HN1997000154A (da)
HR (1)	HRP970640A2 (da)
ID (1)	ID18964A (da)
MA (1)	MA26450A1 (da)
PA (1)	PA8441701A1 (da)
PE (1)	PE17099A1 (da)
PT (1)	PT944611E (da)
TN (1)	TNSN97191A1 (da)
WO (1)	WO1998023603A1 (da)
ZA (1)	ZA9710587B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001053477A1 (en) *	2000-01-20	2001-07-26	Baylor College Of Medicine	Methods and compositions for control of bone formation via modulation of neuropeptide y activity
US20060165683A1 (en)	2001-12-05	2006-07-27	Gerard Karsenty	Methods and compositions for control of bone formation via modulation of sympathetic tone
EP1470228B1 (en)	2002-01-09	2006-03-29	Arexis AB	Detection of mutations
PT1701722E (pt) *	2004-11-23	2009-12-10	Dong Wha Pharm Co Ltd	Sal do ácido n-hidroxi-4-{5-[4-(5-isopropil-2-metil-1,3-tiazol- 4-il)fenoxi]pentoxi}benzamidina-2-metanossulfónico
WO2006108218A1 (en) *	2005-04-15	2006-10-19	Regenertech Pty Limited	Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL321136A1 (en) *	1994-11-07	1997-11-24	Pfizer	Some substituted derivatives of bencylamine as a new class of specific ligands of neuropeptide y1

1997
- 1997-11-18 PA PA19978441701A patent/PA8441701A1/es unknown
- 1997-11-18 US US08/972,470 patent/US5914329A/en not_active Expired - Fee Related
- 1997-11-19 AU AU47924/97A patent/AU4792497A/en not_active Abandoned
- 1997-11-19 PT PT97910602T patent/PT944611E/pt unknown
- 1997-11-19 BR BR9713538A patent/BR9713538A/pt not_active Application Discontinuation
- 1997-11-19 AT AT97910602T patent/ATE257472T1/de not_active IP Right Cessation
- 1997-11-19 JP JP10524469A patent/JP3120861B2/ja not_active Expired - Fee Related
- 1997-11-19 DE DE69727155T patent/DE69727155T2/de not_active Expired - Fee Related
- 1997-11-19 ES ES97910602T patent/ES2213207T3/es not_active Expired - Lifetime
- 1997-11-19 PE PE1997001052A patent/PE17099A1/es not_active Application Discontinuation
- 1997-11-19 DK DK97910602T patent/DK0944611T3/da active
- 1997-11-19 EP EP97910602A patent/EP0944611B1/en not_active Expired - Lifetime
- 1997-11-19 CA CA002272927A patent/CA2272927C/en not_active Expired - Fee Related
- 1997-11-19 WO PCT/IB1997/001465 patent/WO1998023603A1/en not_active Ceased
- 1997-11-20 AP APAP/P/1997/001148A patent/AP9701148A0/en unknown
- 1997-11-24 AR ARP970105494A patent/AR010304A1/es unknown
- 1997-11-25 ZA ZA9710587A patent/ZA9710587B/xx unknown
- 1997-11-25 GT GT199700123A patent/GT199700123A/es unknown
- 1997-11-25 MA MA24872A patent/MA26450A1/fr unknown
- 1997-11-25 ID IDP973762A patent/ID18964A/id unknown
- 1997-11-25 TN TNTNSN97191A patent/TNSN97191A1/fr unknown
- 1997-11-26 HN HN1997000154A patent/HN1997000154A/es unknown
- 1997-11-26 HR HR60/031,815A patent/HRP970640A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP3120861B2 (ja)	2000-12-25
ATE257472T1 (de)	2004-01-15
AP9701148A0 (en)	1998-01-31
ID18964A (id)	1998-05-28
DE69727155T2 (de)	2004-07-08
MA26450A1 (fr)	2004-12-20
PT944611E (pt)	2004-04-30
BR9713538A (da)	2000-03-21
US5914329A (en)	1999-06-22
JP2000505110A (ja)	2000-04-25
ES2213207T3 (es)	2004-08-16
HN1997000154A (es)	1999-02-09
AU4792497A (en)	1998-06-22
CA2272927C (en)	2003-02-04
EP0944611B1 (en)	2004-01-07
HRP970640A2 (en)	1998-10-31
EP0944611A1 (en)	1999-09-29
PA8441701A1 (es)	2000-05-24
PE17099A1 (es)	1999-02-19
ZA9710587B (en)	1999-05-25
WO1998023603A1 (en)	1998-06-04
CA2272927A1 (en)	1998-06-04
GT199700123A (es)	1999-05-19
AR010304A1 (es)	2000-06-07
TNSN97191A1 (fr)	2005-03-15
DE69727155D1 (de)	2004-02-12

Publication	Publication Date	Title
DK1064298T3 (da)	2009-01-19	Inhibitorer af caspaser
IS4880A (is)	1998-10-27	Innlyksa kompexar af arýl - heterósýklískum söltum
DK0966430T3 (da)	2002-09-30	Anti-flammatoriske forbindelser
DK1004669T3 (da)	2007-08-27	Hidtil ukendte differentieringsinhibitor
PT996622E (pt)	2003-01-31	Novos compostos heterociclicos espiroazabiciclicos
ATE261935T1 (de)	2004-04-15	Neue metformin salze und verfahren
FI962749L (fi)	1996-09-04	Uusia heterosyklisiä yhdisteitä
DE60142480D1 (de)	2010-08-12	Einstellung von aufnahmebedingungen in einer kamera
DE69932378D1 (de)	2006-08-31	Automatisches Ausrichten von Druckköpfen
FI971635L (fi)	1997-04-17	Menetelmät neuropeptidiin Y liittyvien tilojen inhiboimiseksi
DK0796207T3 (da)	2000-11-27	Bærer af klemmetypen
DK1344524T3 (da)	2006-10-30	Refluksinhibitorer
BR9509610A (pt)	1997-10-28	Ligandos específicos de neuropeptideo Y1
DK0745011T3 (da)	2000-10-02	Dannelse af gevind
DE69811326D1 (de)	2003-03-20	Chromenverbindungen
DK0695383T3 (da)	2002-02-25	Efterbehandling af non-woven-duge
ZA9710587B (en)	1999-05-25	Dimesylate salts of neuropeptide y ligands
DK1035128T3 (da)	2003-10-13	Fremgangsmåde til fremstilling af raffinosekrystaller
DK0950051T3 (da)	2004-01-26	Mikropartikulær form af en tetrahydropyridinforbindelse
DK0883623T3 (da)	2003-04-07	Fremstilling af chirale titanocener
ATA88199A (de)	2002-04-15	Schalbauteil
SE9704542D0 (sv)	1997-12-05	Novel pyridazinone compounds
SE9402122D0 (sv)	1994-06-16	Heterocyclic compounds
SE9400968D0 (sv)	1994-03-23	Heterocyclic compounds
DK0815473T3 (da)	2002-05-13	Bestemmelse af en parameter for en komponent i en sammensætning